Search results for "Hazard"

showing 10 items of 1517 documents

Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction.

2008

Background— An ankle-brachial index (ABI; ratio of ankle and brachial systolic blood pressure) <0.9 indicates peripheral arterial disease (PAD) and is a strong predictor of cardiovascular events. The aim of the present study was to address the prognostic value of different methods of ABI calculation. Methods and Results— In 831 patients admitted with chest pain for diagnostic heart catheterization, blood pressure of both anterior and posterior tibial arteries was measured. ABI was calculated for each leg with the higher of the 2 ankle pressures (current definition of the American Heart Association) or with the lower of the 2 ankle pressures (modified definition) in relation to the highe…

Malemedicine.medical_specialtyBrachial ArteryMyocardial InfarctionBlood PressurePredictive Value of TestsRisk FactorsPhysiology (medical)Internal medicinemedicinePrevalenceHumansAgedProportional Hazards ModelsPeripheral Vascular DiseasesProportional hazards modelbusiness.industryVascular diseaseFollow up studiesMiddle Agedmedicine.diseasePrognosisbody regionsStrokeBlood pressuremedicine.anatomical_structurePredictive value of testsPhysical therapyCardiologyFemaleAnkleCardiology and Cardiovascular MedicinebusinessAnkle JointFollow-Up StudiesCirculation
researchProduct

Non-invasive peripheral vascular function, incident cardiovascular disease, and mortality in the general population

2021

AIMS Evidence suggests that peripheral vascular function is related to cardiovascular disease (CVD) and mortality. We evaluated the associations of noninvasive measures of flow-mediated dilatation and peripheral arterial tonometry with incident CVD and mortality. METHODS AND RESULTS In a post-hoc analysis of the community-based Gutenberg Health Study, median age 55 years (25th/75th percentile 46/65) and 49.5% women, we measured brachial artery flow-mediated dilatation (N = 12,599) and fingertip peripheral arterial tonometry (N = 11,125). After a follow-up of up to 11.7 years, we observed 595 incident CVD events, 106 cardiac deaths, and 860 deaths in total. Survival curves showed decreased e…

Malemedicine.medical_specialtyBrachial ArteryPhysiologyPopulation030204 cardiovascular system & hematologyCohort Studies03 medical and health sciencesVascular Stiffness0302 clinical medicineRisk FactorsPhysiology (medical)medicine.arteryInternal medicinemedicineHumans030212 general & internal medicineBrachial arteryeducationSurvival analysiseducation.field_of_studyProportional hazards modelbusiness.industryHazard ratioMiddle AgedConfidence intervalPeripheralCardiovascular DiseasesCohortCardiologyFemaleEndothelium VascularCardiology and Cardiovascular MedicinebusinessCardiovascular Research
researchProduct

Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival

2004

Heat shock protein 70 (Hsp70) is essential for cellular recovery, survival and maintenance of cellular function. Research into the possible use of Hsp70 as a cytoprotective therapeutic agent is ongoing. Chronic heart failure (CHF) is a state associated with systemic inflammation, particularly in patients with cardiac cachexia. We hypothesised that circulating Hsp70 levels are elevated in patients with CHF, more so in cachechtic patients, and that Hsp70 levels would relate to mortality.We studied 107 patients (28 female, age 67+/-1 years, NYHA class 2.6+/-0.6 and LVEF 29+/-1%, mean+/-SEM) and 21 controls. Cardiac cachexia was present in 32 patients. Hsp70 was detectable in 41% of CHF patient…

Malemedicine.medical_specialtyCachexiaSystemic inflammationSeverity of Illness IndexCachexiaDisease severityInternal medicineHumansMedicineHSP70 Heat-Shock ProteinsIn patientcardiovascular diseasesAgedHeart FailureEjection fractionProportional hazards modelbusiness.industryMiddle Agedmedicine.diseaseHsp70Survival RateEndocrinologyCase-Control StudiesHeart failureChronic Diseasecardiovascular systemCardiologyCytokinesFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transpl…

2020

BACKGROUND There is a lack of data on the use of direct-acting antivirals (DAA) on the risk of death and tumoral recurrence in patients with hepatitis C virus (HCV) and hepatocellular carcinoma (HCC) listed for liver transplantation (LT). We aimed to assess the impact of antiviral treatment on mortality and HCC recurrence patients with HCC-HCV. METHODS This was a retrospective multicenter study of patients with HCC-HCV listed for LT from 2005 to 2015. Patients were divided according to the antiviral treatment received after HCC diagnosis: DAA, interferon (IFN), or no antiviral. Intention-to-treat overall survival and HCC recurrence incidence were compared by the Kaplan-Meier method. Multiva…

Malemedicine.medical_specialtyCarcinoma HepatocellularTime FactorsWaiting Listsmedicine.medical_treatment030230 surgeryLiver transplantationGastroenterologyAntiviral AgentsRisk Assessment03 medical and health sciences0302 clinical medicineInterquartile rangeRisk FactorsInternal medicineCarcinomamedicineHumansRisk factorRetrospective StudiesTransplantationbusiness.industryIncidence (epidemiology)Hazard ratioLiver NeoplasmsRetrospective cohort studyMiddle Agedmedicine.diseaseHepatitis Cdigestive system diseasesLiver TransplantationTreatment OutcomeHepatocellular carcinoma030211 gastroenterology & hepatologyFemaleNeoplasm Recurrence LocalbusinessTransplantation
researchProduct

Tumor Marker Carbohydrate Antigen 125 Predicts Adverse Outcome After Transcatheter Aortic Valve Implantation

2013

ObjectivesThis study sought to predict the value of tumor marker carbohydrate antigen 125 (CA125) before and after transcatheter aortic valve implantation (TAVI) for all-cause death and a composite endpoint of death, admission for heart failure, myocardial infarction, and stroke (major adverse cardiac events [MACE]).BackgroundRisk stratification after TAVI remains challenging. The use of biomarkers in this setting represents an unmet need.MethodsCA125 was measured in 228 patients before and after TAVI. The association with outcomes was assessed using parametric Cox regression and joint modeling for baseline and longitudinal analyses, respectively. CA125 was evaluated as logarithm transforma…

Malemedicine.medical_specialtyCardiac CatheterizationTime FactorsAortic Valve InsufficiencyMyocardial InfarctionKaplan-Meier EstimateRisk AssessmentCA125Interquartile rangeRisk FactorsInternal medicineMedicineHumansMyocardial infarctionLongitudinal StudiesRegistriesStroketranscatheter aortic valve implantationTumor markerAgedProportional Hazards ModelsAged 80 and overHeart FailureHeart Valve Prosthesis ImplantationProportional hazards modelbusiness.industryMembrane ProteinsAortic Valve Stenosismedicine.diseasejoint modelingHospitalizationStrokeLogistic ModelsTreatment OutcomeCardiovascular DiseasesHeart failureCA-125 AntigenMultivariate AnalysisCardiologybiomarkerBiomarker (medicine)FemaleprognosisbusinessCardiology and Cardiovascular MedicineMaceBiomarkersJACC: Cardiovascular Interventions
researchProduct

Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure.

2020

This study was designed to assess hemodynamic changes in response to transcatheter tricuspid valve edge-to-edge repair (TTVR) and to identify hemodynamic predictors associated with mortality.Severe tricuspid regurgitation (TR) is associated with high mortality. TTVR effectively alleviates heart failure symptoms, but comprehensive hemodynamic characterization of patients undergoing TTVR is currently lacking.This international, multicenter study included 236 patients undergoing TTVR. Data from clinical assessment, echocardiography, intraprocedural right heart catheterization, and noninvasive cardiac output measurement were analyzed. Hemodynamic predictors for mortality were identified using l…

Malemedicine.medical_specialtyCardiac CatheterizationTime FactorsHemodynamicsRegurgitation (circulation)030204 cardiovascular system & hematologyNew york heart association03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumans030212 general & internal medicineTRICUSPID VALVE REPAIRAgedHeart FailureHeart Valve Prosthesis ImplantationTricuspid valvebusiness.industryProportional hazards modelHemodynamicsRecovery of Functionmedicine.diseaseTricuspid Valve Insufficiencymedicine.anatomical_structureTreatment OutcomeMulticenter studyHeart failureCardiologyFemaleTricuspid ValveCardiology and Cardiovascular MedicinebusinessJACC. Cardiovascular interventions
researchProduct

Randomized comparison between the invasive and conservative strategies in comorbid elderly patients with non-ST elevation myocardial infarction.

2016

Abstract Background Comorbid elderly patients with non-ST-elevation myocardial infarction (non-STEMI) are underrepresented in randomized trials and undergo fewer cardiac catheterizations according to registries. Our aim was to compare the conservative and invasive strategies in these patients. Methods Randomized multicenter study, including 106 patients (January 2012–March 2014) with non-STEMI, over 70 years and with comorbidities defined by at least two of the following: peripheral artery disease, cerebral vascular disease, dementia, chronic pulmonary disease, chronic renal failure or anemia. Patients were randomized to invasive (routine coronary angiogram, n = 52) or conservative (coronar…

Malemedicine.medical_specialtyCardiac Catheterizationmedicine.medical_treatmentComorbidityKaplan-Meier Estimate030204 cardiovascular system & hematologyRevascularizationCoronary Angiography03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicineMedicineHumans030212 general & internal medicineMyocardial infarctionProspective StudiesRegistriesAngioplasty Balloon CoronaryProspective cohort studyNon-ST Elevated Myocardial InfarctionCardiac catheterizationAgedProportional Hazards ModelsAged 80 and overbusiness.industryProportional hazards modelCardiovascular Agentsmedicine.diseaseComorbidityTreatment OutcomeSpainHeart failureCardiovascular agentCardiologyFemalebusinessEuropean journal of internal medicine
researchProduct

Sex differences on new-onset heart failure in patients with known or suspected coronary artery disease

2021

Abstract Aims The impact of sex in patients with CAD has been widely reported, but little is known about the influence of sex on the risk of new-onset HF in patients with known or suspected CAD. We aimed to examine sex-related differences and new-onset heart failure (HF) risk in patients with known or suspected coronary artery disease (CAD) undergoing vasodilator stress cardiac magnetic resonance (CMR). Methods and results We prospectively evaluated 5899 consecutive HF-free patients submitted to stress CMR for known or suspected CAD. Ischaemic burden (number of segments with stress-induced perfusion deficit) and left ventricular ejection fraction (LVEF) were assessed by CMR. The association…

Malemedicine.medical_specialtyCardiac magnetic resonanceEpidemiologymedicine.medical_treatmentHeart failureCoronary Artery DiseaseRevascularizationCoronary artery diseaseVentricular Function LeftCoronary artery diseaseInternal medicineHumansMedicinecardiovascular diseasesMyocardial infarctionHeart FailureSex CharacteristicsEjection fractionbusiness.industryHazard ratioStroke VolumePrognosismedicine.diseaseConfidence intervalHeart failureCardiologyFemaleSexCardiology and Cardiovascular MedicinebusinessPerfusion
researchProduct

Mediterranean Diet Reduces the Adverse Effect of the TCF7L2-rs7903146 Polymorphism on Cardiovascular Risk Factors and Stroke Incidence

2013

OBJECTIVE Transcription factor 7-like 2 (TCF7L2) polymorphisms are strongly associated with type 2 diabetes, but controversially with plasma lipids and cardiovascular disease. Interactions of the Mediterranean diet (MedDiet) on these associations are unknown. We investigated whether the TCF7L2-rs7903146 (C>T) polymorphism associations with type 2 diabetes, glucose, lipids, and cardiovascular disease incidence were modulated by MedDiet. RESEARCH DESIGN AND METHODS A randomized trial (two MedDiet intervention groups and a control group) with 7,018 participants in the PREvención con DIetaMEDiterránea study was undertaken and major cardiovascular events assessed. Data were analyzed at b…

Malemedicine.medical_specialtyCardiovascular and Metabolic RiskMediterranean dietEndocrinology Diabetes and MetabolismPopulationType 2 diabetesDiet MediterraneanGastroenterologylaw.inventionRandomized controlled triallawRisk FactorsDiabetes mellitusInternal medicineInternal MedicinemedicineOdds RatioHumanseducationTriglyceridesOriginal ResearchAgedAdvanced and Specialized Nursingeducation.field_of_studyPolymorphism Geneticbusiness.industryIncidenceHazard ratioOdds ratioFastingMiddle Agedmedicine.diseaseStrokeEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesFemalebusinessTCF7L2Transcription Factor 7-Like 2 ProteinDiabetes Care
researchProduct

Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort

2021

Real-world evidence on the course of Hepatitis C Virus (HCV) chronic liver disease after Sustained Virologic Response (SVR) obtained with direct-acting antiviral drugs (DAAs) are still limited, and the effects on mortality remain unclear. We evaluated the post-treatment survival of 4307 patients in the RESIST-HCV cohort (mean age 66.3 ± 11.6 years, 56.9% males, 24.7% chronic hepatitis, 66.9% Child-Pugh A cirrhosis and 8.4% Child-Pugh B cirrhosis) treated with DAAs between March 2015 and December 2016 and followed for a median of 73 weeks (range 16–152). Proportional cause-specific hazard regression for competing risks was used to evaluate the survival and to assess the predictors of liver a…

Malemedicine.medical_specialtyCirrhosisHepatitis C virusChronic Hepatitis; Cirrhosis; Competing risks; Survival.Hepacivirusmedicine.disease_causeChronic liver diseasecompeting riskAntiviral AgentsGastroenterologysurvivalchronic hepatitiVirologyDiabetes mellitusInternal medicinemedicineHumanschronic hepatitis cirrhosis competing risks survivalAgedcompeting risksHepatologybusiness.industrycirrhosisHazard ratioAlbuminOriginal ArticlesHepatitis C ChronicMiddle Agedmedicine.diseaseHepatitis Cdigestive system diseasesInfectious DiseasesCardiovascular DiseasesCohortOriginal ArticleFemalechronic hepatitisbusinessKidney diseasecirrhosi
researchProduct